The resounding success of OpenAI’s LLM ChatGPT has sparked a fervent era of artificial intelligence (AI) enthusiasm, setting off a competitive frenzy among established tech titans to introduce their own cutting-edge AI offerings.
In the midst of this technological race, Google Bard, the brainchild of Alphabet (NASDAQ: GOOGL), has taken the spotlight as a commanding force in the realm of generative AI. Boasting an impressive repertoire of capabilities, Google Bard’s prowess extends to the realm of predicting forthcoming trends within the financial markets, drawing the rapt attention of discerning stock investors.
Against this backdrop, on August 7, Finbold turned to Bard for insights, seeking to construct a meticulously curated stock portfolio with a modest $1,000 budget. Notably, Bard’s choice leaned towards a collection of five elite blue-chip stocks, including none other than Google itself.
Picked for you
It’s worth highlighting that each of these five chosen stocks—Apple (NASDAQ: AAPL), Microsoft (NASDAQ: MSFT), (NASDAQ: AMZN), Alphabet, and (NASDAQ: NFLX)—stands as a prominent player within the respective tech sector. Significantly, Bard proposes allocating the majority of the $1,000 portfolio budget to Apple, constituting a quarter of the total, while allocating the smallest portion of $100 each to Google and Netflix stocks.
Bard picks a diversified portfolio
Highlighted by Finbold’s analysis, the stock portfolio in focus reveals a significant tilt toward the dynamic tech sector. Noteworthy, Bard acknowledges that this tilt might give rise to concerns for those in pursuit of a finely diversified investment array.
Given the inherent volatility within the tech domain, there looms a plausible scenario wherein portfolio value could undergo a setback should the tech sector encounter a downturn. Bard acknowledged, “This could be a concern if you are looking for a well-diversified portfolio.”
“To improve the diversification of this portfolio, you could consider adding some stocks from other sectors, such as healthcare, finance, or consumer staples. You could also consider adding some bonds to your portfolio, which would help to reduce your risk.”
The revamped portfolio model showcases distinct inclusions. Procter & Gamble is a global stalwart within consumer staples. Renowned for its mastery across categories spanning laundry essentials, oral care, and infant products,
Johnson & Johnson (NYSE: JNJ) is a titan within the global healthcare panorama. Its dominance extends across pharmaceuticals, medical apparatus, and consumer health merchandise, thus imparting a reassuring stabilizing effect.
Rounding off this trinity is Walmart (NYSE: WMT), an unequivocal trailblazer in the realm of retail. Boasting an extensive network of brick-and-mortar establishments coupled with a robust digital presence.
Disclaimer: The content on this site should not be considered investment advice. Investing is speculative. When investing, your capital is at risk.